drugset / Trial / NCT00800592

Sildenafil IV Bolus Study

NCT00800592

Phase 1 Completed 12 enrolled Viatris Inc.
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to assess the safety, tolerability and pharmacokinetics of intravenous sildenafil (10 mg) administered as a bolus injection to patients with Pulmonary Arterial Hypertension already receiving and stable on oral Revatio 20 mg TID.

Timeline

Start
2008-10
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 10 mg Intravenous